Mass Tort brief
Mass Tort Brief: Medtronic Bellwether Verdict and UK Group Action Precedents
US jury orders Medtronic to pay $88M in hernia mesh trial as UK courts refine binding rules for group litigation and collective actions.
Mass Tort
Medtronic lost an $88M hernia mesh bellwether trial — adverse jury verdicts increase settlement pressure across 10,000 pending claims.
BackgroundBellwether trials serve as test cases in multi-district litigation to gauge jury reactions and help parties evaluate settlement ranges. Over 10,000 similar surgical mesh claims remain pending against Medtronic, a key NHS device supplier.
- The jury awarded $77 million in compensatory damages to patient Larry Patterson and $11 million to his spouse, establishing a high benchmark for future cases.
- Plaintiffs demonstrated that the resorbable collagen barrier degraded in seven days rather than the advertised 30 days, causing widespread internal scarring.
- Medtronic is a primary surgical device supplier to the NHS, where regulatory scrutiny over mesh implants remains intense following UK safety reviews.
Mass Tort
The Supreme Court clarified GLO group litigation rules — trial judges gain flexibility when precedent shifts during group suits.
BackgroundGroup Litigation Orders manage multiple opt-in claims sharing common legal issues across courts in England and Wales. Rulings on designated test issues usually bind all registered claimants automatically.
- The Supreme Court ruled in Axa Insurance v HMRC regarding CPR 19.23 procedural binding mechanisms, establishing clear exceptions for group registers.
- Judges retain explicit discretion to grant relief from test case rulings if subsequent legal developments create obvious injustice across group registers.
- The precedent directly impacts active UK group actions, giving claimants in long-running environmental and financial mis-selling suits room to adjust strategy.
Mass Tort
The CAT approved a drop-hands settlement in the £480M Which? suit — tribunals are tightening scrutiny on unviable class actions.
BackgroundThe Competition Appeal Tribunal hears opt-out collective proceedings brought under the Consumer Rights Act 2015. Drop-hands settlements resolve ongoing litigation with neither party paying financial compensation to the other.
- The £480 million opt-out claim was brought on behalf of 29 million UK smartphone owners targeting Qualcomm's patent licensing practices.
- Following a five-week trial, the Tribunal assessed the claim's likelihood of ultimate success at under 10%, justifying the zero-payout exit.
- The approval sets a critical precedent that increases judicial scrutiny over unviable opt-out claims and speculative litigation funding arrangements.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.